As of Aug 28
| -0.10 / -0.56%|
The 7 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 25.00, with a high estimate of 38.00 and a low estimate of 9.00. The median estimate represents a +41.56% increase from the last price of 17.66.
The current consensus among 8 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.